Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
- Research interviews
-
1. The regulation of cell therapy
- Prof. Moutih Rafei
-
2. Artificial intelligence in guiding cancer treatment decisions
- Prof. Eytan Ruppin
-
3. How and why neurons die in Alzheimer's disease?
- Prof. Bart De Strooper
-
4. The future of blood tests in cancer treatment
- Dr. Isaac Garcia-Murillas
-
5. Role of marketing authorization holder in drug safety
- Dr. Raphael Elmadjian Pareschi
-
6. Synthetic whole embryo models and their applications
- Prof. Jacob (Yaqub) Hanna
-
7. Scale-up challenges in the production of nanomedicines from lab to industry
- Prof. Dr. Oya Tagit
-
8. Artificial intelligence in precision medicine
- Dr. Michael P. Menden
-
9. Translational medicine: the risk of failure in delay and how to reduce it
- Prof. Martin Wehling
-
10. Challenges and solutions of scaling up
- Dr. Shaukat Ali
-
12. Management of generic drug development: challenges and opportunities
- Mr. Sandeep Patil
-
13. MassBank development and future
- Dr. Emma L. Schymanski
-
14. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
-
15. Translational research in amyotrophic lateral sclerosis (ALS)
- Prof. Aaron D. Gitler
-
17. PANDAS: a potential link between group A streptococcal infections and neurological disorders
- Prof. P. Patrick Cleary
-
18. Rheumatic diseases and musculoskeletal pain
- Prof. Anisur Rahman
-
19. Towards developing a universal influenza vaccine
- Prof. Peter Palese
- Clinical interviews
-
20. Monkeypox: etiopathogenesis, prevention, and treatments
- Dr. Dennis Hruby
-
21. Kidney xenotransplantation
- Dr. Douglas J. Anderson
-
22. CAR-T and TCR-T cellular immunotherapies in oncology
- Prof. Sebastian Kobold
-
23. MAPS: the business of medical affairs
- Dr. Danie du Plessis
-
24. Hypertrophic cardiomyopathy: therapies and treatments
- Prof. Srihari Naidu
-
25. Combating the HIV epidemic
- Prof. William Blattner
-
26. Epigenetic pharmaceuticals used in the clinic
- Dr. Thomas Paul
-
27. Precision cancer medicine: development and future
- Prof. Maurie Markman
-
28. Pediatric cancer testing
- Prof. Joshua Schiffman
-
29. Opposition to vaccination: a transatlantic discussion
- Prof. Jonathan Temte
-
30. Elective caesarean sections from an evolutionary perspective
- Prof. Wenda Trevathan
-
31. Antiphospholipid syndrome and Lupus
- Prof. Graham Hughes
-
32. Prescribing medications to children - a GP’s view
- Dr. Amanda Simmons
Topics Covered
- Where cancer comes from
- Genetic predisposition, hereditary cancer syndromes, and cancer genes
- The questioned importance of family history
- Complications of current studies and data sets
- The future of genetic testing, studies, and intervention
Biography
Schiffman earned his MD from Brown University, and completed his Pediatric Residency, Pediatric Chief Residency, and Pediatric Hematology/Oncology Fellowship at Stanford University, where he then served as an Instructor and directed the Pediatric Cancer Genetics Clinic (PCGC). In 2008, he joined the University of Utah as an Instructor, as well as an Investigator at Huntsman Cancer Institute. Within one year, he had risen to Assistant Professor in Pediatrics, and was promoted to Associate Professor in 2012.
Dr. Schiffman is dedicated to translating biological and genomic discoveries into clinical advances for patients. His research emphasis is cancer susceptibility in families, with a focus on the genomic changes underlying pediatric cancer development. He is pursuing copy number changes related to leukemia and sarcoma development, and functional assays related to risk of hereditary cancers. He is involved with the Utah Population Database (UPDB) to understand the risk factors associated with cancer development in children and their families. Dr. Schiffman runs a translational genomics research laboratory, where he combines both epidemiological and comparative oncology perspectives to advance the understanding of why children develop cancer. Dr. Schiffman is a member of several national and international research cooperative groups related to cancer risk and genetic epidemiology. He is also the Principal Investigator of the Cancer Genetics Study (CGS) which enrolls high risk families for genomic analysis. Dr. Schiffman has written more than 150 publications, scientific papers, chapters, and abstracts.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Schiffman, J. (2020, April 14). Pediatric cancer testing [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 30, 2024, from https://doi.org/10.69645/KGAS7826.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Joshua Schiffman has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.